Bill Text: NY A05580 | 2023-2024 | General Assembly | Introduced

---

Bill Title: Requires retail licensees for on-premises consumption of alcohol and adult-use on-site consumption of cannabis licensees have opioid antagonists to be administered to patrons, staff or individuals on premises of such establishment.

Spectrum: Moderate Partisan Bill (Republican 4-1)

Status: (Introduced) 2024-01-03 - referred to economic development [A05580 Detail]

Download: New_York-2023-A05580-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          5580

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                     March 16, 2023
                                       ___________

        Introduced by M. of A. K. BROWN -- read once and referred to the Commit-
          tee on Economic Development

        AN ACT to amend the alcoholic beverage control law and the cannabis law,
          in relation to requiring certain businesses in which alcohol or canna-
          bis is consumed to have opioid antagonists

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Section 106  of  the  alcoholic  beverage  control  law  is
     2  amended by adding a new subdivision 18 to read as follows:
     3    18.  All retail licensees for on-premises consumption shall contain an
     4  opioid antagonist to be administered to patrons, staff or individuals on
     5  premises of such establishment.  For the purposes of  this  subdivision,
     6  "opioid  antagonist"  means  naloxone,  narcan  or  any other medication
     7  approved by the department of health  and  the  federal  food  and  drug
     8  administration  that, when administered, negates or neutralizes in whole
     9  or in part the pharmacological effects of an opioid in the human body.
    10    § 2. Section 77 of the cannabis law is amended by adding a new  subdi-
    11  vision 15 to read as follows:
    12    15.  Each  adult-use  on-site  consumption  licensee  shall contain an
    13  opioid antagonist to be administered to patrons, staff or individuals on
    14  premises of such establishment.  For the purposes of  this  subdivision,
    15  "opioid  antagonist"  means  naloxone,  narcan  or  any other medication
    16  approved by the department of health  and  the  federal  food  and  drug
    17  administration  that, when administered, negates or neutralizes in whole
    18  or in part the pharmacological effects of an opioid in the human body.
    19    § 3. This act shall take effect on the ninetieth day  after  it  shall
    20  have become a law.


         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD06542-01-3